DK142145B - Modificeret opiumsalkaloidantigen til anvendelse ved fremstilling af et antistof til brug ved påvisning af tilstedeværelsen af et opiumsalkaloid i en biologisk væske. - Google Patents

Modificeret opiumsalkaloidantigen til anvendelse ved fremstilling af et antistof til brug ved påvisning af tilstedeværelsen af et opiumsalkaloid i en biologisk væske. Download PDF

Info

Publication number
DK142145B
DK142145B DK228271AA DK228271A DK142145B DK 142145 B DK142145 B DK 142145B DK 228271A A DK228271A A DK 228271AA DK 228271 A DK228271 A DK 228271A DK 142145 B DK142145 B DK 142145B
Authority
DK
Denmark
Prior art keywords
antigen
opium alkaloid
antibody
protein
alkaloid
Prior art date
Application number
DK228271AA
Other languages
Danish (da)
English (en)
Other versions
DK142145C (sv
Inventor
Sidney Spector
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to DK443373A priority Critical patent/DK142146B/da
Publication of DK142145B publication Critical patent/DK142145B/da
Application granted granted Critical
Publication of DK142145C publication Critical patent/DK142145C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
DK228271AA 1970-05-13 1971-05-12 Modificeret opiumsalkaloidantigen til anvendelse ved fremstilling af et antistof til brug ved påvisning af tilstedeværelsen af et opiumsalkaloid i en biologisk væske. DK142145B (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK443373A DK142146B (da) 1970-05-13 1973-08-10 Opiumsalkaloid-specifikt antistof til brug ved påvisning af et opiumsalkaloid i en biologisk væske.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3699970A 1970-05-13 1970-05-13
US3699970 1970-05-13

Publications (2)

Publication Number Publication Date
DK142145B true DK142145B (da) 1980-09-08
DK142145C DK142145C (sv) 1981-02-02

Family

ID=21891894

Family Applications (1)

Application Number Title Priority Date Filing Date
DK228271AA DK142145B (da) 1970-05-13 1971-05-12 Modificeret opiumsalkaloidantigen til anvendelse ved fremstilling af et antistof til brug ved påvisning af tilstedeværelsen af et opiumsalkaloid i en biologisk væske.

Country Status (5)

Country Link
CA (1) CA966778A (sv)
DE (1) DE2166716C3 (sv)
DK (1) DK142145B (sv)
GB (1) GB1320056A (sv)
SE (4) SE389739B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104367A (en) * 1976-10-13 1978-08-01 Hoffmann-La Roche Inc. Radioimmunoassay for methadone
CN113968853B (zh) * 2020-07-22 2022-09-16 中国农业大学 阿托品类生物碱的半抗原、人工抗原及其制备方法与应用

Also Published As

Publication number Publication date
DE2166716A1 (de) 1975-04-24
CA966778A (en) 1975-04-29
SE417970B (sv) 1981-04-27
SE7408140L (sv) 1974-06-19
SE389739B (sv) 1976-11-15
SE389737B (sv) 1976-11-15
GB1320056A (en) 1973-06-13
DE2166716B2 (de) 1979-09-27
DE2123300A1 (de) 1971-11-25
DK142145C (sv) 1981-02-02
SE7408141L (sv) 1974-06-19
DE2166716C3 (de) 1980-06-12
DE2123300B2 (de) 1976-03-04

Similar Documents

Publication Publication Date Title
US3709868A (en) Opium alkaloid antigens and antibodies specific therefor
Ranadive et al. Antibodies to serotonin
US3766162A (en) Barbituric acid antigens and antibodies specific therefor
CN104160273B (zh) 用于免疫抑制剂药物的夹心测定
EP2888263A1 (en) Haptens of risperidone and paliperidone
US20060088933A1 (en) Reagents for detecting efavirenz
DK157340B (da) Fremgangsmaade til fremstilling af et pancreatisk glucagonspecifikt antistof
US3704282A (en) Catecholamine antigens and antibodies specific therefor
US20040248222A1 (en) Monoclonal antibodies specific for buprenorphine and metabolites thereof
US4078049A (en) Acetylcholine assay
JPS6057254A (ja) 免疫学的測定法による糖脂質の定量方法
CN102336831A (zh) 一种抗西地那非的特异性抗体
DK142145B (da) Modificeret opiumsalkaloidantigen til anvendelse ved fremstilling af et antistof til brug ved påvisning af tilstedeværelsen af et opiumsalkaloid i en biologisk væske.
US3976763A (en) Chlorpromazine assay
US20060240496A1 (en) Immunogens, derivatives and immunoassay for ethyl glucuronide
CN101717443A (zh) 一种苄嘧磺隆人工免疫原be-bsa及其制备和用途
JPS5888660A (ja) ヨードチロニン免疫複合体に対する抗体
US6814951B1 (en) Acetaldehyde and malondialdehyde protein adducts as markers for alcohol liver disease
CN108690118B (zh) 一种用于Lp-PLA2、NGAL和Derf24增强免疫的方法
US4094964A (en) Clonidine assay
US6120777A (en) High fluorescence specific immune enhancing factor and methods of use for same
JPS607362A (ja) 酵素を用いた抗原決定基具有物質の測定法
EP0016594B1 (en) Steroidal phosphonothioate compounds, process for preparing them, compositions containing said compounds, process for preparing said compositions, method of producing an antiserum and method of radioimmunoassay
CN108178793A (zh) 一种用于偶联sncg、lp-pla2和11-脱氢血栓烷增强免疫的载体蛋白制备方法
DK142146B (da) Opiumsalkaloid-specifikt antistof til brug ved påvisning af et opiumsalkaloid i en biologisk væske.